HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Probing platinum-adenine-n3 adduct formation with DNA minor-groove binding agents.

Abstract
Me-lex(py/py), an adenine-N3-selective alkylating agent, and the reversible minor-groove binder netropsin were used to probe the formation of unusual minor-groove adducts by the cytotoxic hybrid agent PT-ACRAMTU ([PtCl(en)(ACRAMTU)](NO(3))(2); en = ethane-1,2-diamine, ACRAMTU = 1-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea). PT-ACRAMTU was found by chemical footprinting to inhibit specific Me-lex-mediated DNA cleavage at several adenine sites but not at nonspecific guanine, which is consistent with the platination of adenine-N3. In a cell proliferation assay, a significant decrease in cytotoxicity was observed for PT-ACRAMTU, when cancer cells were pretreated with netropsin, suggesting that minor-groove adducts in cellular DNA contribute to the biological activity of the hybrid agent.
AuthorsLu Rao, Tiffany K West, Gilda Saluta, Gregory L Kucera, Ulrich Bierbach
JournalChemical research in toxicology (Chem Res Toxicol) Vol. 23 Issue 7 Pg. 1148-50 (Jul 19 2010) ISSN: 1520-5010 [Electronic] United States
PMID20578739 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Alkylating Agents
  • DNA Adducts
  • Organoplatinum Compounds
  • Netropsin
  • Adenine
Topics
  • Adenine (chemistry)
  • Alkylating Agents (chemistry, toxicity)
  • DNA Adducts (chemistry)
  • DNA Cleavage (drug effects)
  • Netropsin (pharmacology)
  • Organoplatinum Compounds (chemistry, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: